NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









AustinPx

AustinPx

Private
Georgetown, TexasHealthcare & Life Scienceshttps://www.austinpx.com/

Last Round

Series C

Oct 16, 2020

Total Funding Raised

$53.7M

Company Overview

AustinPx is a pharmaceutical services company that provides contract development and manufacturing organization (CDMO) services, specializing in bioavailability enhancement and oral dosage form development.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

contract development and manufacturing organizationCDMObioavailability enhancementformulation developmentdrug formulationKinetiSolamorphous solid dispersionGMP manufacturingsmall molecule drugsdrug solubilityclinical trial materialpharma outsourcinganalytical servicesdrug delivery technologysolvent-free processing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

AustinPx Comparables

Compare AustinPx with similar companies based on industry and business-model similarity.

AustinPx comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Ascendia
88%
Ascendia Pharmaceutical Solutions
88%
Serán Bioscience
85%

AustinPx Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series COct 16, 2020
Early FundingApr 26, 2018
Early FundingNov 9, 2016
Early FundingFeb 3, 2015

Key People

Founding team and executive leadership

Elizabeth Hickman

Chief Executive Officer

Executive Team

Chris Brough

Chief Technology Officer

Executive Team

AustinPx Investors

Notable investors and investment history

AustinPx investors
InvestorRounds
Research Corporation TechnologiesEarly Funding

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 26, 2018

    $27M raised, led by Research Corporation Technologies.

  • Feb 3, 2015

    $10M raised, led by Research Corporation Technologies.

AustinPx Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

AustinPx Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about AustinPx's valuation, stock price, and market status.

Firmographic Details

HeadquartersGeorgetown, Texas
Employee Range45
Year Founded2007
Last FundingOct 16, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.